KALVKalVista Pharmaceuticals, Inc.Mar 25, 2026Q1 2025
Read transcript →KalVista Pharmaceuticals, Inc. (KALV) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$19.19
+0.16%
Mkt Cap $977.33M
KALVKalVista Pharmaceuticals, Inc.Mar 25, 2026KALVKalVista Pharmaceuticals, Inc.Nov 11, 2025Q3 2025
Read transcript →KALVKalVista Pharmaceuticals, Inc.Sep 11, 2025Q1 2026
Read transcript →